Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer

por Delahaye, Celia, Figarol, Sarah, Pradines, Anne, Favre, Gilles, Mazieres, Julien, Calvayrac, Olivier
Publicado 2022

Vγ9Vδ2 T Cells Activation Through Phosphoantigens Can Be Impaired by a RHOB Rerouting in Lung Cancer

por Laplagne, Chloé, Meddour, Sarah, Figarol, Sarah, Michelas, Marie, Calvayrac, Olivier, Favre, Gilles, Laurent, Camille, Fournié, Jean-Jacques, Cabantous, Stéphanie, Poupot, Mary
Publicado 2020

The RAS‐related GTPase RHOB confers resistance to EGFR‐tyrosine kinase inhibitors in non‐small‐cell lung cancer via an AKT‐dependent mechanism

por Calvayrac, Olivier, Mazières, Julien, Figarol, Sarah, Marty‐Detraves, Claire, Raymond‐Letron, Isabelle, Bousquet, Emilie, Farella, Magali, Clermont‐Taranchon, Estelle, Milia, Julie, Rouquette, Isabelle, Guibert, Nicolas, Lusque, Amélie, Cadranel, Jacques, Mathiot, Nathalie, Savina, Ariel, Pradines, Anne, Favre, Gilles
Publicado 2016